13 April 2018 | News
The transaction, if consummated, will be an all-stock deal via a tax-free exchange of shares.
Singapore- Boston Therapeutics inks a non-binding letter of intent with Medical Technology Associates to acquire MTA, a privately-held company dedicated to the development of novel biopharmaceuticals through its proprietary ALTAPURE technology. ALTAPURE technology is a proprietary process for purification and stabilization applied to purify biological extractions, e.g. blood products (animal), pituitary gland, pancreas and botanicals, specialty proteins, creating molecules of enhanced purity (quality) for biopharmaceutical development and volume for commercialization (quantity in kilograms).